-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Anti-Viral Cellular Immunotherapies

Symposia: Scientific Workshop on Viruses in Hematology: Emerging Challenges and Therapeutic Vulnerabilities Program: Scientific Workshops
Friday, December 8, 2023: 4:13 PM-4:53 PM
Room 8 (San Diego Convention Center)
Moderator:
and Keri Toner, MD, Children's National Hospital
Disclosures:
No relevant conflicts of interest to declare.
Moderator Introduction

Keri Toner, MD

Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC
Restoration of Sars-COV-2-Specific T-Cell Immunity

Spyridoula Vasileiou

Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX
Poly-Virus Specific T Cells As Prophylaxis Against BK, Vzv, CMV, EBV, Flu, Polyoma Virus and Fungal Infections after HSCT

Emily Blyth, MD, PhD

Westmead Hospital, Sydney, Australia; Westmead Institute for Medical Research, Westmead, Nsw, Australia; Faculty of Medicine and Health, University of Sydney, Sydney, Australia
Trials and Tribulations - Autologous and 3rd Party EBV T Cell Immunotherapy

Rayne Rouce, MD

Texas Children's Hospital, Houston, TX
Panel Discussion
See more of: Scientific Workshop on Viruses in Hematology: Emerging Challenges and Therapeutic Vulnerabilities
See more of: Scientific Workshops
<< Previous Session | Next Session >>